Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. A voluntarily given, written signed dated data sharing consent from participants and/or legally acceptable representative. 2. Participants of 18 years and above of either gender who are newly prescribed Isotretinoin or who have not used oral isotretinoin for past one month for the management of acne and moisturiser (Excela) as an adjuvant therapy as per Investigatorââ?¬•s discretion.
Exclusion criteria
Exclusion criteria: 1.Any skin allergy or serious skin condition or unsuitable to participate in the study as per routine clinical practice. 2.Pregnant and lactating women 3.Participated in any clinical trial within 1 month from screening
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Investigator Assessment at end of week 4 2.Subject Assessment at end of week 4Timepoint: 1. Investigator Assessment at end of week 4 2. Subject Assessment at end of week 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate effectiveness and tolerability of moisturiser in acne patients who are prescribed isotretinoin.Timepoint: day 1, day 28 | — |
Countries
India
Contacts
Cipla Ltd